SEER
SeerยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
SEER Profile
Seer, Inc.
A leading provider of artificial intelligence-powered software for life sciences and pharmaceutical companies, offering a suite of solutions for data analysis and visualization
Life Science Tools and Services
03/16/2017
12/04/2020
NASDAQ Stock Exchange
134
12-31
Common stock
3800 Bridge Parkway, Suite 102, Redwood City, California 94065
--
Seer, Inc., was incorporated in Delaware on March 16, 2017. The company aims to achieve superior scientific results by commercializing transformational products that provide researchers with in-depth, unbiased bioinformation. The company's initial product, the Proteograph product suite, will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, in-depth, fast and large-scale access across the proteome. The company's protein mapping product suite is an integrated solution consisting of consumables, automated instruments and software. The company's protein map provides an easy-to-use workflow that has the potential to perform proteomic analysis and analyze thousands of samples to characterize the complex, dynamic nature of the proteome and can be used in almost any laboratory.
